N/A
Completed N=61
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
HIV · Sexually Transmitted Diseases · Risk Reduction · Pre-Exposure Prophylaxis
Source: ClinicalTrials.gov NCT03177512 ↗
Enrolled (actual)
61
Serious AEs
0.0%
Results posted
May 2021
Primary outcomePrimary: Acceptability — 75.63 units on a scale
Summary
This study is testing the acceptability and feasibility of a highly interactive mobile application (app) to promote HIV/sexually transmitted infection (STI) testing and uptake of pre-exposure prophylaxis (PrEP) among young men who have sex with men (YMSM).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability |
75.63 | — |
| PRIMARY Feasibility: Number of Participants Who Opened the App at Least Once by Month 3 Time Point |
38 | — |
| SECONDARY Frequency of App Use |
15.16 | — |
| SECONDARY Number of Participants Using Different Parts of the App |
38; 37; 37; 33; 35; 34 | — |
| SECONDARY Number of Participants Who Ordered HIV/STI Home Testing Kits, Condoms and Lube |
38; 37; 29; 19 | — |
| SECONDARY Number of Participants Reporting HIV Testing Over 6 Months |
28; 11 | — |
| SECONDARY PrEP Uptake as Measured by Self Report |
5; 4 | — |
Eligibility Criteria
Inclusion Criteria
- No HIV test in the past 3 months (self-reported).
- Not known to be HIV-infected (self-reported).
- Not currently taking PrEP (self-reported).
- Owns an Apple operating system (iOS) or Android mobile phone and willing and able to download the LYNX app onto their phone.
- Willing and able to attend an in-person baseline visit in the Tampa or Chicago area.
- Able to understand, read, and speak English.
- Participants ages 15-18: self-report at least one episode of anal intercourse with a male or transfemale partner during the last 6 months
- Participants ages 19-24: self-report evidence of high risk for acquiring HIV infection including at least one of the following:
- at least one episode of condomless anal sex with an HIV-positive or unknown HIV status male or transfemale partner during the last 6 months; or
- Anal sex with 2 or more male and/or transfemale partners during the last 6 months; or
- Exchange of money, gifts, shelter, or drugs for anal sex with a male or transfemale partner during the last 6 months; or
- Sex with a male or transfemale partner and has had an STI during the last 6 months.
Exclusion Criteria
- Currently enrolled in another HIV intervention study
- Prior enrollment in an HIV vaccine trial with receipt of experimental vaccine product
- Enrollment in an earlier phase of LYNX study
- Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Data sourced from ClinicalTrials.gov (NCT03177512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.